More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$347247813
EPS
-14.58
P/E ratio
--
Price to sales
0.56
Dividend yield
--
Beta
2.048327
Previous close
$2.34
Today's open
$2.32
Day's range
$2.30 - $2.37
52 week range
$2.30 - $15.70
show more
CEO
Irwin D. Simon
Employees
2650
Headquarters
Leamington, ON
Exchange
Nasdaq Global Select
Shares outstanding
147787523
Issue type
Common Stock
Healthcare
Pharmaceuticals
Tilray Brands stock has crashed to a record low: is this fallen angel a buy?
Tilray Brands stock extended its sell-off this week, sinking to a record low as concerns about the company intensified. The shares fell to $2.34, leaving them down 74% so far this year, 55% over the past six months, and 98% over the past five years.
Invezz • Nov 17, 2026

Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?
Tilray has been aggressively pursuing acquisitions in recent years. Its focus has largely been on loading up on craft brewers in the U.S. market.
The Motley Fool • Nov 16, 2026

Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club
A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access
GlobeNewsWire • Nov 11, 2026

Does Marijuana Rescheduling Really Help Tilray's Stock?
Rescheduling marijuana to a lower level makes the substance easier to research and results in lower tax bills for companies. Tilray, however, is a Canadian producer and won't directly see any benefits from rescheduling.
The Motley Fool • Nov 10, 2026

Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?
Tilray is consolidating its operations in Canada to simplify its business and achieve cost savings. The company announced new guidance for adjusted EBITDA that is slightly higher at the low end than before.
The Motley Fool • Nov 9, 2026

Tilray Brands, Inc. (TLRY) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Tilray Brands (TLRY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks Investment Research • Nov 5, 2026

Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth
Consolidation of Foss Cultivation and Pre-roll Production into Optimized Masson and Cayuga Facilities Expected to Generate Approximately US$10 Million in Annualized Cost Savings Higher Cultivation Yields and Expected Reestablishment of EU-GMP Certification Strengthen Tilray's Canadian Cannabis Platform and Position the Business for Continued Growth in Canada, International Markets, and Future U.S. Medical Cannabis Markets When Permissible Tilray Raises Fiscal 2027 Adjusted EBITDA Guidance to $70 Million–$75 Million, Increasing the Lower End of the Range NEW YORK and LONDON and LEAMINGTON, Ontario, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company with leading positions across cannabis, beverage, hospitality and wellness, today announced plans to consolidate its Canadian cannabis operations, transitioning cultivation and pre-roll production from its Foss facility in Fenwick, Ontario to its Masson, Quebec and Cayuga, Ontario facilities. This strategic initiative is expected to generate approximately US$10 million in annualized cost savings by the end of fiscal 2028.
GlobeNewsWire • Nov 2, 2026

Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?
Tilray reported record quarterly revenue of $257.1 million. Cannabis revenue declined 13% despite strong international growth.
The Motley Fool • Nov 1, 2026

Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing
Tilray Brands has shifted from a marijuana company to a global brand manager across marijuana, beverages, and wellness. The company's fiscal first quarter 2027 earnings highlight just how much the business has changed.
The Motley Fool • Nov 1, 2026

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.
The Motley Fool • Oct 30, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Tilray Brands Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.